Bush Jennifer
COO, CLO, Compliance Officer
Bush Jennifer has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Bush Jennifer is listed as COO, CLO, Compliance Officer at Artiva Biotherapeutics, Inc. Inside the rolling window, Bush Jennifer reported no open-market purchases and 3 open-market sales totaling $230K in ARTV. The largest disclosed transaction in the window is a sale of 8,391 ARTV shares on Sep 3, 2026, worth $94K.
Companies traded
Other insiders at ARTV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$230K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bush Jennifer made?
Bush Jennifer has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Bush Jennifer trade?
Bush Jennifer has filed SEC Form 4 disclosures for 1 company, including ARTV.
When was Bush Jennifer's most recent SEC Form 4 filing?
Bush Jennifer's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Bush Jennifer's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bush Jennifer is listed as COO, CLO, Compliance Officer.
What is Bush Jennifer's total buy and sell value in the current window?
Inside the rolling retention window, Bush Jennifer bought $0 and sold $230K based on SEC Form 4 filings.
What was Bush Jennifer's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,391 ARTV shares on 2026-09-03, worth $94K, per SEC Form 4 filings.